China reports new progress in drug, therapies against Covid-19


Researchers working at the drug centre for Covid-19 cure at a company in Wuqing District, north China's Tianjin Municipality. China has completed the clinical research of Favipiravir, an antiviral drug that has shown good clinical efficacy against the Covid-19 (coronavirus) outbreak, according to an official on Tuesday (March 17). - Xinhua/ANN

BEIJING: China has completed the clinical research of Favipiravir, an antiviral drug that has shown good clinical efficacy against the Covid-19 (coronavirus) outbreak, according to an official on Tuesday (March 17).

Favipiravir, the influenza drug which was approved for clinical use in Japan in 2014, has shown no obvious adverse reactions in the clinical trial, said Zhang Xinmin, director of the China National Center for Biotechnology Development under the Ministry of Science and Technology, at a press conference.

Article type: metered
User access status: 3
Join our Telegram channel to get our Evening Alerts and breaking news highlights
   

Next In Regional

UK interested in working with Malaysia to develop rail industry Premium
No flood in KL Sentral as alleged, say Brickfields cops Premium
China’s digital yuan goes to school with student card that gives parents control over spending Premium
Covid-19: Sarawak aims to get 80% of children vaxxed by end of June Premium
Police officer to be suspended for allegedly taking upskirt video of woman in Hong Kong’s financial district Premium
All short and medium-term LRT improvements already implemented, says Transport Ministry Premium
Climate change will cause more floods, forest fires in Malaysia, says Bomba chief Premium
Flash floods hit Sekinchan, drainage hampered by high tide Premium
'Pay more attention' Ethereum co-founder says of crypto crash Premium
S&P: Malaysia to continue leading Islamic banking growth in southeast Asia Premium

Others Also Read